Nurse Practitioner, Family · Alhambra, CA
NPI
1538454277
Since 2011
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
726 E Main St Unit B
Alhambra, CA, 91801
Phone (626) 773-3388
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.6M
8,052 prescriptions
Company payments, 2025
$3,366
From 19 companies
Medicare prescription drug claims, 2024
In 2024, the drug Ling Lee prescribed most often to Medicare patients was Atorvastatin Calcium, with 713 prescriptions and refills. In total Ling Lee wrote 8,052 Medicare prescriptions that cost $2.6M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 713 | 2,010 | 191 | $5,506 |
| Rosuvastatin Calcium Generic | 285 | 758 | 74 | $2,863 |
| Losartan Potassium Generic | 260 | 711 | 70 | $1,949 |
| Amlodipine Besylate Generic | 255 | 721 | 77 | $1,110 |
| Metoprolol Succinate Generic | 190 | 534 | 57 | $2,808 |
| Kerendia Finerenone | 187 | 295 | 33 | $177K |
| Metformin Hcl Generic | 186 | 511 | 56 | $1,322 |
| Farxiga Dapagliflozin Propanediol | 183 | 283 | 40 | $150K |
| Tamsulosin Hcl Generic | 172 | 452 | 45 | $1,874 |
| Vascepa Icosapent Ethyl | 168 | 326 | 34 | $61K |
| Irbesartan Generic | 159 | 439 | 42 | $2,908 |
| Jardiance Empagliflozin | 156 | 275 | 31 | $148K |
| Levothyroxine Sodium Generic | 147 | 380 | 33 | $1,290 |
| Prolia Denosumab | 135 | 810 | 80 | $210K |
| Repatha Sureclick Evolocumab | 127 | 201 | 30 | $105K |
Brand drugs: 2,682 claims; generic drugs: 5,317 claims; opioid claims: 72.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ling Lee $3,366 ($3,366 in general payments such as food, travel and fees) from 19 companies. The largest payer was Amgen Inc. with $717.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 36 | $717 |
| Phathom Pharmaceuticals, Inc. PHAT | 8 | $392 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $357 |
| GlaxoSmithKline, LLC. GSK | 18 | $319 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 13 | $311 |
| Novo Nordisk Inc NVO | 8 | $159 |
| Gilead Sciences, Inc. GILD | 9 | $155 |
| Ardelyx, Inc. ARDX | 5 | $137 |
| Aimmune Therapeutics, Inc. | 5 | $132 |
| IBSA Pharma Inc. | 6 | $119 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.